| Purpose of the guideline: |
Anovulatory infertility is a common and difficult disease for women of childbearing age. The World Health Organization ranks it as the third largest disease after tumor and cardiovascular and cerebrovascular diseases. The incidence rate of ovulation induced infertility is increasing year by year. Ovulation dysfunction is one of the main causes of female infertility, including persistent anovulation, rare ovulation and inappropriate ovulation, including polycystic ovary syndrome, hyperprolactinemia, early-onset ovarian insufficiency / premature ovarian failure / decline of ovarian reserve function, corpus luteum insufficiency, luteinized unruptured follicle syndrome and other diseases. The combination of dialectical and disease differentiation of integrated traditional Chinese and Western medicine has unique advantages and exact curative effect. It can avoid and reduce the adverse reactions and side effects of Western medicine, reduce complications, adverse reactions and toxic and side effects, give full play to the characteristics of individualized and accurate diagnosis and treatment, effectively solve the reproductive needs of patients, significantly improve their quality of life, and provide economic, safe and Effective treatment. Different from the exogenous hormone replacement therapy in modern medicine, traditional Chinese medicine can fundamentally regulate women's reproductive function, improve the state of endocrine disorder, restore normal ovulation and improve the pregnancy rate, and the long-term effect is ideal. However, at present, there is still a lack of standardized clinical guidelines for the treatment of ovulatory infertility with integrated traditional Chinese and Western medicine, and there is no systematic evidence-based evaluation research. In order to give full play to the advantages and characteristics of integrated traditional Chinese and Western medicine, it is very necessary to formulate relevant guidelines. |
